• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » AUA co-sponsoring public FDA workshops

AUA co-sponsoring public FDA workshops

April 24, 2013
CenterWatch Staff

The American Urological Association (AUA) will co-host two FDA public workshops to address research in the areas of bladder and prostate cancer. The events, free and open to the public, will take place in San Diego on May 5 and May 6, during the AUA's annual scientific meeting.

These educational workshops are designed to provide beneficial and comprehensive information on clinical trials to both medical professionals and the general public. Panels will discuss trial designs and study endpoints for prostate and bladder cancer trials, as well as strategies to foster clinical cancer research.

The first event, "Clinical Trial Design Issues: Drug and Device Development for Localized Prostate Cancer" will be held on May 5 from 8 a.m. to 5 p.m. and will feature key leaders in the field of prostate cancer, including physicians, advocates and industry representatives from a variety of specialties, including urology, radiation oncology, medical oncology, biostatistics and experts in clinical trial methodology. The second, "Clinical Trial Design Issues: Development of New Therapies for Non-Muscle Invasive Bladder Cancer" will take place on May 6 from 1 p.m.

to 5 p.m. Both events will be held at the Manchester Grand Hyatt Hotel in San Diego.

"The overall objective of this workshop is to discuss and develop new pathways for drug approval in localized prostate and bladder cancer," said Dr. Johannes Vieweg, chair of the AUA's Research Council. Drug or device development is currently hampered by a lack of validated clinical trial endpoints and this workshop is designed to aid with accelerating the pipeline of new drugs and devices with benefit to our patients.

More information about the prostate cancer workshop can be found online by visiting the FDA website.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing